- Condition: Blood Coagulation Disorders
Intervention: Drug: Dabigatran Etexilate 110 mg
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Capital Health, Canada; Dalhousie University; Université de Montréal
Not yet recruiting - verified April 2012 - Condition: Drug Mechanism
Intervention: Drug: Lithium Carbonate
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified April 2012 - Conditions: Colles Fracture; Point of Care Ultrasound; Emergency Ultrasound
Intervention: Device: Point of care ultrasound
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified April 2012 - Conditions: Pain; Development
Interventions: Behavioral: Kangaroo Mother Care; Dietary Supplement: Sucrose
Sponsors: IWK Health Centre; IWK Health Centre; Canadian Institutes of Health Research (CIHR); Nova Scotia Health Research Foundation; The Mayday Fund
Not yet recruiting - verified March 2012 - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Behavioral: Teacher Help for ADHD
Sponsors: Dalhousie University; Dalhousie University
Recruiting - verified March 2012 - Conditions: Diabetes; Stroke; Obesity
Intervention:
Sponsors: Children's & Women's Health Centre of British Columbia; Children's & Women's Health Centre of British Columbia
Recruiting - verified March 2012 - Condition: Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified February 2012 - Condition: Mild Cognitive Impairment
Intervention: Behavioral: Cognitive training
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Nova Scotia Health Research Foundation
Not yet recruiting - verified February 2012 - Condition: Colonoscopy
Intervention: Device: Magnetic Endoscopic Imaging (MEI) colonoscopy
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified November 2011 - Condition: Preterm Infants
Interventions: Procedure: Milking the umbilical cord at birth; Procedure: immediate umbilical cord clamping
Sponsors: IWK Health Centre; Walid El-Naggar
Recruiting - verified December 2011 - Condition: Cardiac Sarcoidosis
Intervention:
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Ontario Ministry of Health and Long Term Care
Not yet recruiting - verified December 2011 - Conditions: Pregnancy; Microcirculation
Intervention:
Sponsors: IWK Health Centre; IWK Health Centre
Completed - verified January 2012 - Condition: Movement Disorders
Intervention: Other: Wheelchair skills training program
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified September 2011 - Conditions: Heart Failure; Atrial Fibrillation
Interventions: Procedure: Catheter ablation-based AF rhythm control; Drug: Medication Rate Control
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Lithium; Drug: Paroxetine
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified August 2011 - Condition: Kidney Neoplasms
Interventions: Device: Quill knotless tissue-closure device; Device: 2-0 absorbable vicryl suture
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified August 2011 - Condition: Osteochondritis Dissecans of Ankle and Joints of Foot
Intervention: Other: Weight-Bearing as Tolerated
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified July 2011 - Condition: Marital Relationship
Intervention: Behavioral: Hold Me Tight
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Dalhousie University
Withdrawn - verified September 2011 - Conditions: Esophageal Cancer; Adenocarcinoma, Esophageal; Squamous Cell Carcinoma, Esophageal; Carcinoma, Gastroesophageal Junction
Interventions: Drug: carboplatin and paclitaxel; Other: Carboplatin paclitaxel plus concurrent radiotherapy
Sponsors: Capital District Health Authority, Canada; Gordon Buduhan; Capital Health, Canada
Recruiting - verified January 2012 - Condition: Hypotension
Interventions: Drug: Phenylephrine bolus; Drug: phenylephrine infusion
Sponsors: IWK Health Centre; IWK Health Centre
Recruiting - verified January 2012 - Conditions: Oppositional Defiant Disorder; Behaviour Disorder
Intervention: Behavioral: Strongest Families Intervention (formerly Family Help)
Sponsors: IWK Health Centre; IWK Health Centre; Canadian Institutes of Health Research (CIHR)
Recruiting - verified November 2011 - Condition: Advanced Rare Tumours
Interventions: Drug: Sunitinib; Drug: Temsirolimus
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Conditions: Cognitive Impairment; Stroke
Intervention: Behavioral: Telerehabilitation Cognitive Strategy Training
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; IWK Health Centre; Canadian Institutes of Health Research (CIHR)
Recruiting - verified August 2011 - Condition: Vaccine Exposure During Pregnancy
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Li Ka Shing Foundation; PHAC/CIHR Influenza Research Network
Active, not recruiting - verified June 2011 - Condition: Physical Activity
Interventions: Behavioral: Transformational Teaching; Behavioral: Standard Educational Practices
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified January 2012 - Condition: Influenza Vaccine
Interventions: Biological: Agriflu; Biological: Fluad; Biological: Intanza; Biological: Vaxigrip
Sponsors: University of British Columbia; University of British Columbia; PHAC/CIHR Influenza Research Network
Active, not recruiting - verified March 2012 - Condition: Physical Activity
Intervention: Behavioral: Exercise Videogame Bikes
Sponsors: University of Victoria; University of Victoria; Canadian Cancer Society; University of British Columbia; Dalhousie University; University of Auckland, New Zealand
Recruiting - verified June 2011 - Condition: Atherosclerosis
Intervention:
Sponsors: Canadian Atherosclerosis Imaging Network; Canadian Atherosclerosis Imaging Network; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Conditions: Disease Due to BK Polyomavirus; Kidney Transplant Infection
Intervention: Drug: Levofloxacin
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR); St. Paul's Hospital, Canada; Vancouver General Hospital; University of Alberta; University of Manitoba; University Health Network, Toronto; St. Michael's Hospital, Toronto; St. Joseph's Healthcare Hamilton; London Health Sciences Centre; McGill University Health Center; Dalhousie University
Recruiting - verified March 2012 - Conditions: Psychotic Disorders; Schizophrenia
Intervention: Other: skin test
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified December 2011 - Condition: Influenza
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Conditions: Epilepsy; Seizures
Intervention:
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Nova Scotia Health Research Foundation
Recruiting - verified December 2011 - Conditions: Stroke; Gait, Hemiplegic
Intervention:
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified February 2011 - Condition: Wheelchairs
Intervention:
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified February 2011 - Condition: Acute Kidney Injury
Intervention:
Sponsors: Biosite; Biosite
Recruiting - verified February 2012 - Condition: Defect of Articular Cartilage
Intervention: Device: Augment Bone Graft
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified June 2011 - Condition: Stroke
Interventions: Behavioral: modified constraint induced movement therapy (mCIMT); Other: Usual and Customary Care
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Dalhousie University; Sunnybrook Research Institute
Recruiting - verified December 2011 - Conditions: Complications; Neurostimulator; Satisfaction
Intervention: Device: Neuromodulation
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Completed - verified March 2012 - Condition: Osteoarthritis
Intervention: Device: ADM Cup
Sponsors: Dalhousie University; Dalhousie University
Recruiting - verified March 2012 - Condition: Bipolar Affective Disorder
Intervention: Drug: Mood stabilizer treatment
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified April 2012 - Condition: Postoperative Pain
Interventions: Drug: Saline placebo; Drug: Ropivicaine
Sponsors: IWK Health Centre; IWK Health Centre
Completed - verified July 2009 - Condition: Osteoarthritis
Interventions: Procedure: OtisMed; Procedure: Computer Assisted Surgery (CAS)
Sponsors: Dalhousie University; Dalhousie University
Recruiting - verified March 2012 - Condition: Lung Diseases
Interventions: Device: Exercise DVD; Behavioral: Usual Care
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Capital Health, Canada
Recruiting - verified July 2011 - Condition: Glaucoma
Intervention: Drug: Bevacizumab
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified June 2011 - Condition: Airway Management
Intervention:
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Suspended - verified October 2011 - Condition: Chronic Neuropathic Pain
Interventions: Drug: Methadone; Drug: Controlled Release Morphine
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Canadian Institutes of Health Research (CIHR); Nova Scotia Health Research Foundation; Dalhousie University
Not yet recruiting - verified July 2011 - Condition: Anxiety Sensitivity
Intervention: Other: Distance-based Cognitive Behavioural Therapy
Sponsors: Dalhousie University; Dalhousie University
Active, not recruiting - verified January 2012 - Condition: Gestational Hypertension
Interventions: Procedure: Intervention is blood pressure management approach; Procedure: Intervention is blood pressure management approach.
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute
Recruiting - verified December 2011 - Conditions: Leukemia; Solid Tumours
Intervention: Drug: SB939
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified April 2012 - Condition: Pulmonary Embolism
Intervention:
Sponsors: Sir Mortimer B. Davis - Jewish General Hospital; Sir Mortimer B. Davis - Jewish General Hospital
Recruiting - verified July 2010 - Condition: Ventricular Tachycardia
Intervention:
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified July 2010 - Condition: Melanoma
Interventions: Drug: rIL-21; Drug: Dacarbazine
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Conditions: Acute Coronary Syndrome; ST Elevation Myocardial Infarction; Percutaneous Coronary Intervention
Intervention: Procedure: Percutaneous Coronary Intervention with or without manual aspiration thrombectomy
Sponsors: Population Health Research Institute; Population Health Research Institute
Recruiting - verified March 2012 - Condition: Alcohol Consumption
Interventions: Behavioral: Computer-based Personalized Assessment Feedback; Behavioral: Computer-based sham
Sponsors: University of Alberta; University of Alberta; Norlien Foundation; Women and Children's Health Research Institute, Canada
Recruiting - verified April 2012 - Condition: Multiple Myeloma
Intervention: Drug: AT9283
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Depression
Interventions: Behavioral: Intensive Short-term Dynamic Psychotherapy; Behavioral: Medical treatment as Usual
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified July 2011 - Condition: 18FDG
Intervention:
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified June 2010 - Condition: Recurrent Breast Cancer
Intervention: Drug: Foretinib
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Colonoscopy
Intervention:
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified May 2010 - Condition: Indeterminate Thyroid Nodules
Interventions: Procedure: Total Thyroidectomy + CLND; Procedure: Total thyroidectomy - CLND; Procedure: Hemi-thyroidectomy + CLND; Procedure: Hemi-thyroidectomy - CLND
Sponsors: University of Alberta; University of Alberta; Dalhousie University
Recruiting - verified July 2011 - Condition: Acute Respiratory Failure
Intervention:
Sponsors: Hospital Universitario Getafe; Hospital Universitario Getafe
Completed - verified May 2012 - Condition: Prostate Cancer
Intervention: Drug: HDAC inhibitor SB939
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified March 2012 - Condition: Cardiac Surgery
Interventions: Procedure: Remote Ischemic Preconditioning; Procedure: Sham
Sponsors: McMaster University; Hamilton Health Sciences Corporation; Canadian Network and Centre for Trials Internationally
Active, not recruiting - verified May 2012 - Condition: Cognition
Intervention: Drug: Niaspan
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified November 2009 - Conditions: Chronic Obstructive Pulmonary Disease; Nocturnal Desaturation
Interventions: Device: Concentrator; Device: Sham concentrator
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Conditions: Oral Cancer; High-grade Precancer
Interventions: Procedure: Fluorescence visualization device; Procedure: Fluorescence visualization device
Sponsors: University of British Columbia; University of British Columbia; Terry Fox Research Institute; British Columbia Cancer Agency
Recruiting - verified December 2011 - Condition: Cellulitis
Interventions: Drug: IV cefazolin plus oral probenecid and placebo cephalexin; Drug: Oral cephalexin and saline IV plus probenecid placebo
Sponsors: Kelowna General Hospital; Kelowna General Hospital; Canadian Society of Hospital Pharmacists; Capital Health, Canada; Interior Health, Canada
Recruiting - verified June 2011 - Condition: Lung Cancer
Interventions: Drug: PF-00299804; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Opioid (morphine sulphate) in low dose
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Canadian Institutes of Health Research (CIHR); Nova Scotia Health Research Foundation; Atlantic Health Sciences Corporation
Active, not recruiting - verified December 2011 - Conditions: Male Infertility; Varicoceles
Intervention: Procedure: Varicocelectomy
Sponsors: Mount Sinai Hospital, Canada; Mount Sinai Hospital, Canada; McGill University; Dalhousie University; McMaster University
Not yet recruiting - verified August 2011 - Condition: Fibromyalgia Pain
Intervention: Other: CFQ Qigong
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Completed - verified October 2011 - Condition: Meningococcal C Disease
Intervention: Biological: Neisvac-C (Meningococcal C Conjugate Vaccine)
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Condition: Renal Transplant Immunosuppression
Intervention: Drug: mycophenolate mofetil
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Active, not recruiting - verified January 2012 - Conditions: Stroke; Mobility
Intervention: Other: wheelchair skills training
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified November 2011 - Conditions: Gait; Balance
Intervention:
Sponsors: Capital District Health Authority, Canada; Kim Parker
Recruiting - verified August 2011 - Conditions: Pregnancy; Thrombophilia; Pregnancy Complications
Interventions: Drug: dalteparin sodium 5,000 IU prefilled syringes (antenatal); Drug: dalteparin sodium (after delivery - Control group)
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Condition: Low Back Pain
Intervention:
Sponsors: Capital District Health Authority, Canada; Mary Lynch
Active, not recruiting - verified October 2011 - Conditions: Spinal Cord Trauma; Pain
Interventions: Drug: Lyrica; Drug: pregabalin; Drug: matching placebo; Drug: matching placebo
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Enrolling by invitation - verified April 2009 - Condition: Thoracic Aortic Vascular Disease
Intervention: Procedure: Repair of descending thoracic aneurysm and morphine
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified April 2009 - Condition: Neuropathic Pain
Intervention: Drug: Sativex
Sponsors: Capital District Health Authority, Canada; Mary Lynch
Recruiting - verified October 2011 - Condition: Thromboembolism
Intervention: Drug: Pradax
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Ross K Leighton MD FRCSC
Withdrawn - verified May 2009 - Condition: Non Union Diaphyseal Fractures
Interventions: Device: Infuse Bone Morphogenic Protein (BMP) 2; Procedure: iliac crest autograft
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Canadian Orthopaedic Trauma Society
Withdrawn - verified February 2009 - Condition: Chronic Kidney Disease
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified November 2011 - Conditions: Triage; Pediatrics
Intervention:
Sponsors: St. Justine's Hospital; St. Justine's Hospital; SickKids Foundation; Canadian Institutes of Health Research (CIHR)
Completed - verified July 2011 - Condition: Hematoma
Interventions: Drug: low molecular weight heparin or unfractionated heparin; Drug: Warfarin or coumadin
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Condition: Venous Thromboembolism
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Heart and Stroke Foundation of Ontario
Recruiting - verified June 2011 - Condition: Postoperative Pain
Interventions: Drug: Placebo; Drug: Pregabalin 150 mg
Sponsors: IWK Health Centre; IWK Health Centre
Recruiting - verified July 2011 - Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive BladderCondition: Overactive Bladder
Interventions: Behavioral: Dietary Caffeine reduction; Drug: Anticholinergic medication
Sponsors: IWK Health Centre; IWK Health Centre
Recruiting - verified July 2011 - Conditions: Postoperative Pain; Opioid Use
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsors: IWK Health Centre; IWK Health Centre
Completed - verified November 2011 - Condition: Uterine Atony
Intervention: Drug: Oxytocin infusion
Sponsors: IWK Health Centre; IWK Health Centre
Completed - verified November 2008 - Condition: Hypotension
Intervention: Drug: Phenylephrine bolus
Sponsors: IWK Health Centre; IWK Health Centre
Completed - verified October 2008 - Condition: Breast Cancer
Interventions: Drug: letrozole; Other: placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group; North Central Cancer Treatment Group; Southwestern Oncology Group (SWOG); Cancer and Leukemia Group B
Active, not recruiting - verified May 2012 - Conditions: Lung Cancer; Tobacco Use Disorder
Interventions: Other: laboratory biomarker analysis; Other: screening questionnaire administration; Procedure: bronchoscopic and lung imaging studies; Procedure: computed tomography; Procedure: endoscopic biopsy; Procedure: quality-of-life assessment
Sponsors: British Columbia Cancer Agency; British Columbia Cancer Agency
Active, not recruiting - verified March 2012 - Condition: Influenza
Intervention: Biological: Inactivated Influenza Vaccine Trivalent Types A and B (Split Virion)
Sponsors: British Columbia Centre for Disease Control; British Columbia Centre for Disease Control
Completed - verified July 2011 - Condition: Osteoarthritis
Interventions: Device: Fully coated Prodigy stem; Device: Cemented Endurance Stem
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Completed - verified May 2008 - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Smoking
Interventions: Drug: Bupropion HCl ER; Drug: Placebo
Sponsors: McGill University; Mark Eisenberg; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec
Completed - verified May 2008 - Conditions: Cataract; Phacoemulsification; Mydriasis; Pseudoexfoliation Syndrome
Intervention: Procedure: Intracameral injection of mydriatic agent
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified May 2008 - Condition: Non Small Cell Lung Cancer
Interventions: Dietary Supplement: melatonin; Dietary Supplement: placebo
Sponsors: The Canadian College of Naturopathic Medicine; The Canadian College of Naturopathic Medicine; The Ottawa Hospital
Recruiting - verified February 2012 - Conditions: Clinically Isolated Syndromes; Early Single Relapse of Multiple Sclerosis
Interventions: Drug: Apo-Minocycline; Drug: Placebo Comparator
Sponsors: University of Calgary; Dr. Luanne Metz; Multiple Sclerosis Society of Canada
Recruiting - verified March 2012 - Condition: Respiratory Insufficiency of Prematurity
Intervention: Other: Titration of oxygen therapy
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Conditions: Leukemia; Myelodysplastic Syndromes
Intervention: Drug: cytarabine
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Genetic: DNA methylation analysis; Procedure: quality-of-life assessment; Radiation: Radiation
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; European Organization for Research and Treatment of Cancer - EORTC; Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified March 2012 - Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Doxorubicin; Drug: Cytarabine; Drug: Methotrexate; Drug: Vincristine; Drug: Cyclophosphamide; Drug: Methylprednisone; Drug: Hydrocortisone Sodium Succinate; Drug: Dexamethasone; Drug: 6-MP; Drug: PEG-Asparaginase; Drug: Imatinib; Drug: Etoposide; Procedure: Radiation Therapy; Drug: E. coli Asparaginase
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute; Massachusetts General Hospital; Children's Hospital Boston
Recruiting - verified August 2011 - Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel; Drug: Leuprolide Acetate (Eligard®); Radiation: Intensity-Modulated Radiotherapy; Radiation: Intensity-Modulated Radiotherapy
Sponsors: Nova Scotia Cancer Centre; Nova Scotia Cancer Centre; department of radiation oncology
Active, not recruiting - verified March 2012 - Conditions: Atrial Fibrillation; Catheter Ablation
Intervention: Other: Aggressive BP lowering
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Nova Scotia Health Research Foundation
Recruiting - verified September 2009 - Condition: Respiratory Insufficiency of Prematurity
Interventions: Device: nCPAP; Device: NIPPV
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Completed - verified March 2012 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: bortezomib; Drug: cyclophosphamide; Drug: prednisone; Drug: vincristine sulfate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Conditions: Degenerative Lumbar Disc Disease; Spondylolisthesis; Spinal Stenosis
Intervention: Device: Infuse Bone Graft BMP-2, Large Kit
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Completed - verified June 2011 - Conditions: Healthy; Wheelchair Users
Intervention: Behavioral: wheelchair skills training
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Terminated - verified July 2009 - Condition: Major Depressive Disorder
Interventions: Drug: paroxetine; Drug: lithium
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Recruiting - verified June 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus; Drug: temozolomide; Genetic: microarray analysis; Other: immunohistochemistry staining method
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Lymphoma
Interventions: Drug: bortezomib; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified June 2011 - Condition: Osteoarthritis
Intervention: Device: Knee Implant
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Active, not recruiting - verified July 2006 - Condition: Osteoarthritis
Intervention: Procedure: Surgical approach for total knee arthroplasty
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Completed - verified May 2008 - Condition: Lung Cancer
Intervention: Radiation: 3-dimensional conformal radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Rectal Cancer
Intervention: Procedure: surgery
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Active, not recruiting - verified March 2010 - Condition: Breast Cancer
Interventions: Radiation: 3D-CRT APBI; Radiation: WBI
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research Alliance
Active, not recruiting - verified July 2011 - Condition: Breast Cancer
Interventions: Drug: letrozole; Other: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; British Medical Research Council; Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified February 2012 - Conditions: Coagulation; Bleeding; Thrombosis
Intervention: Drug: Phytonadione (Vitamin K1)
Sponsors: St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton; McMaster University
Completed - verified July 2011 - Condition: Syncope, Vasovagal, Neurally-Mediated
Intervention: Drug: fludrocortisone acetate
Sponsors: University of Calgary; University of Calgary; Canadian Institutes of Health Research (CIHR)
Completed - verified April 2012 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: cisplatin; Drug: cytarabine; Drug: dexamethasone; Drug: gemcitabine hydrochloride; Other: clinical observation
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: CHOP regimen
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel; Drug: topotecan hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified August 2011 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Biological: epoetin alfa; Biological: filgrastim; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: paclitaxel
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; North Central Cancer Treatment Group; Southwest Oncology Group
Active, not recruiting - verified May 2012 - Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: prednisone; Drug: thalidomide
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Ovarian Cancer
Interventions: Drug: carboplatin; Drug: gemcitabine hydrochloride
Sponsors: National Cancer Institute (NCI); AGO Study Group; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified June 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: paclitaxel; Drug: rebimastat
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified August 2011 - Condition: Sarcoma
Intervention: Drug: alvocidib
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified April 2012 - Condition: Lung Cancer
Interventions: Drug: marimastat; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: dexamethasone; Drug: melphalan; Drug: prednisone
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Drug: octreotide acetate; Drug: tamoxifen citrate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate; Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: vinblastine; Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group
Completed - verified January 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified March 2012
 |
Join Clinical Trials by University in Nova Scotia |
